No, numbers reported are for sales, no trials/pro bono numbers are included in reports.
The whole point of course is that the unfortunate increased incidence of rheumatic fever in Aboriginal children gives an increased no. of mitral valve paediatric patients needing surgical repair.
Rheumatic fever is an "old disease" that no longer occurs in great numbers in the developed world due to better hygiene and antibiotics, however this cohort of patients will mean an accelerated view into what CC can do for
a) Mitral valve repairs and
b) Paediatric patients.
So everyone will eventually benefit from this most unfortunate situation. The patients will get better surgical protheses with the prospect at this stage from all available evidence that revisions will not be necessary, and the coy will generate data at a faster rate for valve repairs and the paediatric population.
- Forums
- ASX - By Stock
- AVR
- Upcoming Quarterly
Upcoming Quarterly, page-39
- There are more pages in this discussion • 76 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$18.90 |
Change
-0.200(1.05%) |
Mkt cap ! $363.3M |
Open | High | Low | Value | Volume |
$18.98 | $19.20 | $18.70 | $167.6K | 8.851K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 49 | $18.90 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$18.95 | 100 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 49 | 18.900 |
1 | 400 | 18.580 |
1 | 300 | 18.520 |
5 | 217 | 18.510 |
2 | 1520 | 18.500 |
Price($) | Vol. | No. |
---|---|---|
18.950 | 100 | 1 |
19.250 | 125 | 1 |
19.500 | 1230 | 1 |
19.800 | 1000 | 1 |
19.990 | 6000 | 1 |
Last trade - 16.10pm 06/06/2024 (20 minute delay) ? |
|
|||||
Last
$18.90 |
  |
Change
-0.200 ( 0.42 %) |
|||
Open | High | Low | Volume | ||
$18.95 | $18.95 | $18.59 | 213 | ||
Last updated 15.51pm 06/06/2024 ? |
Featured News
AVR (ASX) Chart |